Eledon Pharmaceuticals (ELDN) Accumulated Depreciation (2013 - 2016)

Eledon Pharmaceuticals (ELDN) has 4 years of Accumulated Depreciation data on file, last reported at $130000.0 in Q4 2016.

• Quarterly Accumulated Depreciation fell 21.21% year-over-year to $130000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $130000.0 (down 21.21% YoY) and the FY2016 annual result came in at $130000.0, down 21.21% from the prior year.
• Accumulated Depreciation eased to $130000.0 in Q4 2016, from $165000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $165000.0 in Q4 2015 to a low of $43000.0 in Q4 2013.
• A 4-year average of $99000.0 and a median of $94000.0 in 2014 frame the typical range for Accumulated Depreciation.
• Annual changes were most pronounced in 2015 — Accumulated Depreciation soared 184.48% — and 2016, when it retreated 21.21%.
• Tracing ELDN's Accumulated Depreciation over 4 years: stood at $43000.0 in 2013, then soared by 34.88% to $58000.0 in 2014, then jumped by 184.48% to $165000.0 in 2015, then slipped by 21.21% to $130000.0 in 2016.
• The last three Accumulated Depreciation figures came in at $130000.0 (Q4 2016), $165000.0 (Q4 2015), and $58000.0 (Q4 2014), per Business Quant data.